This article was first published by The Times of Israel and is re-posted with permission.
New Israeli research may pave the way for drugs that “turn off the hunger switch” in the human brain with minimal side effects, scientists say.
A receptor in the brain, melanocortin 4 (MC4), is known to control the urge to eat. It has been dubbed the “hunger switch.”
A genetically inherited malfunction with this receptor is believed to be the most common cause of obesity that is triggered by a single gene mutation, impacting an estimated 5 percent of early-onset childhood obesity.
To read the full article, click here.
SEE ALSO: Tel Aviv Named 6th Healthiest City In The World – Report
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli Medical Technologies That Could Change The World
October 09, 2024
Harnessing Our Own Bodies For Side Effect-Free Weight Loss
September 30, 2024
Missing Protein Could Unlock Treatment For Aggressive Lung Cancer
September 17, 2024
No Smoking! Startup's Tiny Answer To Safer Medical Cannabis
September 15, 2024
Facebook comments